Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Premier Health of America Inc V.PHA

Premier Health of America Inc. is a Canadian healthtech company. The Company provides a comprehensive range of outsourced service solutions for healthcare needs to governments, corporations, and individuals. The Company uses its proprietary LiPHe platform to lead the healthcare services sector in digital transformation to provide patients with more accessible care services. The Company operates through two segments: Per Diem and Travel Nurses. The Per Diem segment includes Premier Soin and Code Bleu, two of its Quebec subsidiaries that offer their respective services for nursing and assistance by profile and by region. The Travel nurse segment includes Canadian Health Care Agency, Premier Soin Nordik, Solutions Nursing as well as Solutions Staffing, four of its subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, including in remote regions.


TSXV:PHA - Post by User

Comment by Torontojayon Jul 30, 2024 12:57pm
53 Views
Post# 36154651

RE:Investor Presentation - path for growth

RE:Investor Presentation - path for growth

Stonksonlyup90 wrote:

Do these guys have an updated investor presentation somewhere? 

I see lots of talk on this board about the stock being undervalued. However, they are trading at an EV/EBITDA of roughly 7x... and bought SSI at roughly 4x EBITDA. Unless there is a path to significant EBITDA growth im not sure that I agree. GM % is shrinking and I don't see a lot of opportunity to scale rapidly.


 

Im not sure I agree with this assessment. 

The latest acquisition has been very profitable for them. According to md&a, they generated $2,363k  in operating income over 3 months and 52 days. This works out to annualized operating income of ~ $6.25 m which is phenomenal considering they acquired the company for only 
~ $21m. This is significant returns on invested capital for the company. 

 

 

<< Previous
Bullboard Posts
Next >>